Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
138.07
+7.22 (5.52%)
Oct 31, 2025, 4:00 PM EDT
Merck KGaA Employees
Merck KGaA had 59,020 employees as of December 31, 2024. The number of employees decreased by 3,888 or -6.18% compared to the previous year.
Employees
59,020
Change (1Y)
-3,888
Growth (1Y)
-6.18%
Revenue / Employee
$394,546
Profits / Employee
$53,235
Market Cap
56.89B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 59,020 | -3,888 | -6.18% |
| Dec 31, 2023 | 62,908 | -1,324 | -2.06% |
| Dec 31, 2022 | 64,232 | 3,898 | 6.46% |
| Dec 31, 2021 | 60,334 | 2,207 | 3.80% |
| Dec 31, 2020 | 58,127 | 1,056 | 1.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
Merck KGaA News
- 4 days ago - MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies - Financial Post
- 8 days ago - Merck KGaA: An AI-Resistant Pharma Play - Seeking Alpha
- 9 days ago - Merck KGaA (MKKGY) Analyst/Investor Day - Slideshow - Seeking Alpha
- 15 days ago - Merck KGaA Reaches Deal With U.S. To Cut Prices On IVF Drugs - Nasdaq
- 15 days ago - Merck KGaA (MKGAF) Offers Major IVF Discount in New US Deal - GuruFocus
- 16 days ago - Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs. - MarketWatch
- 16 days ago - Trump announces efforts to expand access to IVF drugs - CNBC
- 16 days ago - Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets - WSJ